Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers

Citation
A. Takeda et al., Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers, ONCOL REP, 7(2), 2000, pp. 333-338
Citations number
20
Categorie Soggetti
Oncology
Journal title
ONCOLOGY REPORTS
ISSN journal
1021335X → ACNP
Volume
7
Issue
2
Year of publication
2000
Pages
333 - 338
Database
ISI
SICI code
1021-335X(200003/04)7:2<333:CSOSVE>2.0.ZU;2-J
Abstract
Vascular endothelial growth factor (VEGF) is known as a potent inducer of a ngiogenesis in various human cancers. Serum VEGF concentrations of colorect al cancer patients was assessed for their clinical significance as a tumor marker. Serum samples were obtained at admission from 24 healthy volunteers and 111 patients with colorectal cancer. Preoperative serum VEGF concentra tions, which are significantly higher than those of healthy controls, refle ct clinical stage progression, depth of invasion, liver metastasis, lymph n ode metastasis and lymphatic invasion. Consequently, detection of VEGF coul d serve as a clinically useful marker for colorectal cancer progression and metastasis independent of other markers.